About
Join us to learn how recent discoveries about the brain tumor microenvironment can drive new therapeutic strategies to overcome tumor immunosuppression.

Achieving effective and sustainable anti-tumor immunity remains a significant challenge in cancer therapy, largely due to tumor immunosuppression. This is particularly pronounced in brain tumors, which create one of the most immunosuppressive tumor microenvironments. A key player in this process are macrophages, which can shift between a pro-inflammatory M1-like state and a pro-tumor M2-like state, contributing to the suppression of immune responses.

In this webinar, we present the latest research on reprogramming the brain tumor microenvironment to enhance anti-tumor immunity. Using advanced spatial tissue analysis combined with in vitro experiments, we will delve into the mechanisms regulating macrophage-dependent tumor immunosuppression in brain cancer. Our findings reveal that the spatial localization of macrophages within the tumor microenvironment influences their functional state, and that pathological tissue remodeling within perivascular niches impacts the activity of tumor-infiltrating lymphocytes.

Key learning objectives will include:
  • Impact of the brain tumor microenvironment on immune cells

  • The role of macrophages in tumor immunosuppression

  • How tissue remodeling could enhance anti-tumor immunity in brain cancer
Presenter
1726675006-b328231e63abb2d2
Theo Mantamadiotis, PhD
Associate Professor and Laboratory Head, Doherty Institute Department of Microbiology and Immunology, The University of Melbourne
Theo is head of the Brain Cancer Biology & Tumour Microenvironment Laboratory, at The University of Melbourne. He completed his PhD at the Ludwig Institute for Cancer Research, then moved to the German Cancer Research Centre, Heidelberg, as a postdoctoral researcher where he generated various conditional mutant and Cre-recombinase transgenic mice targeting several regions in the brain. He then joined Rob Ramsay's laboratory at the Peter MacCallum Cancer, where he was the first to demonstrate that MYB has a critical role in brain development. He was a research academic for 3 years at Monash UniCam MIPS before undertaking a Marie Curie Fellowship for 3 years as a part of European Union Greek-German research program, at the University of Patras in Greece. In 2011 he returned to Melbourne and has been head of the Brain Cancer Biology & Tumour Microenvironment Laboratory since. Using cutting edge technology, his research aims to understand how CREB regulates brain tumour growth, and through the development of novel mouse brain tumour models, his laboratory has shown that the PI3K-CREB signalling-transcription axis regulates brain tumour cell proliferation and differentiation, and that targeting CREB attenuates malignancy. More recently, his laboratory has focussed on spatial mapping of the brain tumour microenvironment, investigating tumour remodelling and cell signalling heterogeneity.
Register To Watch Recording
First Name*
Last Name*
Email Address*
Organization / Company*
Job Title*
Country / Region*
Postal Code*
utm_bmcr_source
Primary area of research*
Cancer
Cardiovascular
Immunology
Infectious Disease
Neuroscience
Other:
I'd like to speak with a specialist about Akoya's spatial biology solutions.*
Yes
No, not at this time
Registration Terms
This event is hosted by the Scientist.com family of companies. Specific brands and sites associated with this event include InsideScientific. By registering and participating, you acknowledge that your personal data will be processed by the webinar platform (BigMarker) and Scientist.com. You also agree to receive email communication from InsideScientific about this webinar and other programs of similar nature. The sponsor of this webinar is Akoya Biosciences; by registering and participating, you acknowledge that your data will be processed in accordance with Akoya Bioscience's privacy policy. You may receive email communication from Akoya Biosciences about this webinar and programs of similar interest. You can withdraw your consent at any time from these communications.
Yes, I consent to the registration terms.*
Yes, I consent to the registration terms.*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.